新型冠状病毒病与肾脏替代治疗

doi:10.16138/j.1673-6087.2021.01.002

摘要/Abstract

关键词: 新型冠状病毒病, 血液透析, 腹膜透析, 肾移植

中图分类号:

R692
R563.1

汤荟, 张春. 新型冠状病毒病与肾脏替代治疗[J]. 内科理论与实践, 2021, 16(01): 4-9.

参考文献 42

[1]	中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志, 2020, 41(2): 145-151.
[2]	Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020, 579(7798): 270-273. doi: 10.1038/s41586-020-2012-7 URL
[3]	Naicker S, Yang CW, Hwang SJ, et al. The novel coronavirus 2019 epidemic and kidneys[J]. Kidney Int, 2020, 97(5): 824-828. doi: 10.1016/j.kint.2020.03.001 URL
[4]	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5 URL
[5]	Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China[J]. N Engl J Med, 2020, 382(18): 1708-1720. doi: 10.1056/NEJMoa2002032 URL
[6]	Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study[J]. Lancet Respir Med, 2020, 8(5): 475-481. doi: 10.1016/S2213-2600(20)30079-5 URL
[7]	Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19[J]. Kidney Int, 2020, 97(5): 829-838. doi: 10.1016/j.kint.2020.03.005 URL
[8]	Xiong F, Tang H, Liu L, et al. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China[J]. J Am Soc Nephrol, 2020, 31(7): 1387-1397. doi: 10.1681/ASN.2020030354 pmid: 32385130
[9]	Wu J, Li J, Zhu G, et al. Clinical features of maintenance hemodialysis patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. Clin J Am Soc Nephrol, 2020, 15(8): 1139-1145. doi: 10.2215/CJN.04160320 URL
[10]	Valeri AM, Robbins-Juarez SY, Stevens JS, et al. Presentation and outcomes of patients with ESKD and COVID-19[J]. J Am Soc Nephrol, 2020, 31(7): 1409-1415. doi: 10.1681/ASN.2020040470 URL
[11]	Goicoechea M, Sánchez Cámara LA, Macías N, et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain[J]. Kidney Int, 2020, 98(1): 27-34. doi: S0085-2538(20)30509-3 pmid: 32437770
[12]	Wang H. Maintenance hemodialysis and COVID-19: sa-ving lives with caution, care, and courage[J]. Kidney Med, 2020, 2(3): 365-366. doi: 10.1016/j.xkme.2020.03.003 URL
[13]	Corbett RW, Blakey S, Nitsch D, et al. Epidemiology of COVID-19 in an urban dialysis center[J]. J Am Soc Nephrol, 2020, 31(8): 1815-1823. doi: 10.1681/ASN.2020040534 URL
[14]	Tang H, Tian JB, Dong JW, et al. Serologic detection of SARS-CoV-2 infections in hemodialysis centers: a multicenter retrospective study in Wuhan, China[J]. Am J Kidney Dis, 2020, 76(4): 490-499. doi: 10.1053/j.ajkd.2020.06.008 URL
[15]	Clarke C, Prendecki M, Dhutia A, et al. High prevalence of asymptomatic COVID-19 infection in hemodialysis patients detected using serologic screening[J]. J Am Soc Nephrol, 2020, 31(9): 1969-1975. doi: 10.1681/ASN.2020060827 URL
[16]	Ajaimy M, Melamed ML. COVID-19 in patients with kidney disease[J]. Clin J Am Soc Nephrol, 2020, 15(8): 1087-1089. doi: 10.2215/CJN.09730620 URL
[17]	Ferrey AJ, Choi G, Hanna RM, et al. A case of novel coronavirus disease 19 in a chronic hemodialysis patient presenting with gastroenteritis and developing severe pulmonary disease[J]. Am J Nephrol, 2020, 51(5): 337-342. doi: 10.1159/000507417 URL
[18]	Wang R, Liao C, He H, et al. COVID-19 in hemodialysis patients: a report of 5 cases[J]. Am J Kidney Dis, 2020, 76(1): 141-143. doi: S0272-6386(20)30612-0 pmid: 32240718
[19]	Bose S, Adapa S, Konala VM, et al. Atypical presentation of novel coronavirus disease 2019 in a peritoneal dialysis patient[EB/J]. J Investig Med High Impact Case Rep, 2020. https://journals.sagepub.com/doi/10.1177/2324709620931238?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&
[20]	Farouk SS, Fiaccadori E, Cravedi P, et al. COVID-19 and the kidney: what we think we know so far and what we don’t[J]. J Nephrol, 2020, 33(6): 1213-1218. doi: 10.1007/s40620-020-00789-y URL
[21]	Malberti F, Pecchini P, Marchi G, et al. When a nephrology ward becomes a COVID-19 ward: the Cremona experience[J]. J Nephrol, 2020, 33(4): 625-628. doi: 10.1007/s40620-020-00743-y pmid: 32430898
[22]	Alberici F, Delbarba E, Manenti C, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection[J]. Kidney Int, 2020, 98(1): 20-26. doi: 10.1016/j.kint.2020.04.030 URL
[23]	Basile C, Combe C, Pizzarelli F, et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2(COVID-19) pandemic in haemodialysis centres[J]. Nephrol Dial Transplant, 2020, 35(5): 737-741. doi: 10.1093/ndt/gfaa069 URL
[24]	Fisher M, Yunes M, Mokrzycki MH, et al. Chronic hemodialysis patients hospitalized with COVID-19-short-term outcomes in Bronx, New York[J], 2020, 1(8): 755-762.
[25]	Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2?[J]. Am J Physiol Renal Physiol, 2020, 318(6): F1454-F1462. doi: 10.1152/ajprenal.00160.2020 URL
[26]	Rabb H. Kidney diseases in the time of COVID-19: major challenges to patient care[J]. J Clin Invest, 2020, 130(6): 2749-2751. doi: 10.1172/JCI138871 URL
[27]	Quintaliani G, Reboldi G, Di Napoli A, et al. Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology[J]. J Nephrol, 2020, 33(4): 725-736. doi: 10.1007/s40620-020-00794-1 pmid: 32621109
[28]	Jiang HJ, Tang H, Xiong F, et al. COVID-19 in peritoneal dialysis patients[J]. Clin J Am Soc Nephrol, 2020, 16(1):121-123. doi: 10.2215/CJN.07200520 URL
[29]	Sachdeva M, Uppal NN, Hirsch JS, et al. COVID-19 in hospitalized patients on chronic peritoneal dialysis: a case series[J]. Am J Nephrol, 2020, 51(8): 669-674. doi: 10.1159/000510259 pmid: 32731215
[30]	Vischini G, D’alonzo S, Grandaliano G, et al. SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis[J]. Kidney Int, 2020, 98(1): 237-238. doi: S0085-2538(20)30531-7 pmid: 32413379
[31]	Gao Y, Xi H, Chen L. Emergency surgery in suspected COVID-19 patients with acute abdomen: case series and perspectives[J]. Ann Surg, 2020, 272(1): e38-e39. doi: 10.1097/SLA.0000000000003961 URL
[32]	ISPD Guideline Committee. Precautionary measures for PD patients[DB/OL]. 2020.
[33]	Alasfar S, Avery RK. The impact of COVID-19 on kidney transplantation[J]. Nat Rev Nephrol, 2020, 16(10): 568-569. doi: 10.1038/s41581-020-00340-z pmid: 32788747
[34]	Zhu L, Xu X, Ma K, et al. Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression[J]. Am J Transplant, 2020, 20(7): 1859-1863. doi: 10.1111/ajt.15869 URL
[35]	Zhang H, Chen Y, Yuan Q, et al. Identification of kidney transplant recipients with coronavirus disease 2019[J]. 2020, 77(6):742-747.
[36]	Akalin E, Azzi Y, Bartash R, et al. Covid-19 and kidney transplantation[J]. N Engl J Med, 2020, 382(25): 2475-2477. doi: 10.1056/NEJMc2011117 URL
[37]	Alberici F, Delbarba E, Manenti C, et al. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia[J]. Kidney Int, 2020, 97(6): 1083-1088. doi: 10.1016/j.kint.2020.04.002 URL
[38]	Columbia University Kidney Transplant Program. Early description of coronavirus 2019 disease in kidney transplant recipients in New York[J]. J Am Soc Nephrol, 2020, 31(6): 1150-1156. doi: 10.1681/ASN.2020030375 URL
[39]	Jung HY, Lim JH, Kang SH, et al. Outcomes of COVID-19 among patients on in-center hemodialysis: an experience from the epicenter in South Korea[J]. J Clin Med, 2020, 9(6): 1688. doi: 10.3390/jcm9061688 URL
[40]	Willicombe M, Thomas D, Mcadoo S. COVID-19 and calcineurin inhibitors: should they get left out in the storm[J]?. J Am Soc Nephrol, 2020, 31(6): 1145-1146. doi: 10.1681/ASN.2020030348 pmid: 32312797
[41]	Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emer-ging impasse of angiotensin blockade[J]. Nephron, 2020, 144(5): 213-221. doi: 10.1159/000507305 URL
[42]	Ahmed O, Brockmeier D, Lee K, et al. Organ donation during the COVID-19 pandemic[J]. Am J Transplant, 2020, 20(11): 3081-3088. doi: 10.1111/ajt.16199 URL

新型冠状病毒病与肾脏替代治疗

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 42

相关文章 15

编辑推荐

Metrics

本文评价

[1]	高健, 王德琴, 周永华, 缪娴静, 陈宇, 景鑫, 王艳. 血清生长刺激表达基因2蛋白和脂蛋白相关磷脂酶A2与维持性血液透析患者心血管事件的关系[J]. 内科理论与实践, 2022, 17(04): 295-300.
[2]	黄晓敏, 章倩莹, 杨俪, 崔岩, 徐天, 王子秋, 王朝晖, 任红, 张春燕. 腹膜透析患者跌倒发生的现况调查[J]. 内科理论与实践, 2022, 17(03): 248-252.
[3]	马龙鑫, 汤杰, 林靖生, 曹青, 陈影, 陈尔真, 何萍. 大型方舱医院临床数据库建设和应用[J]. 诊断学理论与实践, 2022, 21(02): 205-211.
[4]	陈涛, 徐煜, 付学良, 袁志青, 花荣. 持续性非卧床腹膜透析病人并发腹股沟疝的外科治疗[J]. 外科理论与实践, 2021, 26(5): 425-429.
[5]	王莉. 血液透析管理[J]. 内科理论与实践, 2021, 16(01): 1-3.
[6]	洪大情. 血液透析信息化建设[J]. 内科理论与实践, 2021, 16(01): 15-17.
[7]	占志朋, 谢席胜, 张凌. 维持性血液透析合并难治性继发性甲状旁腺功能亢进患者甲状旁腺激素水平与骨密度的关系[J]. 内科理论与实践, 2021, 16(01): 45-48.
[8]	樊雪强, 刘鹏. 血液透析通路狭窄的发生机制及防治[J]. 外科理论与实践, 2019, 24(04): 289-292.
[9]	张凌, 熊敏,. 肾移植与三发性甲状旁腺功能亢进[J]. 内科理论与实践, 2018, 13(04): 197-201.
[10]	张春燕, 汪知玉, 杨俪, 黄晓敏, 施咏梅, 王朝晖, 任红, 陈晓农,. “学校式”磷教育在腹膜透析高磷患者中的运用[J]. 内科理论与实践, 2018, 13(04): 227-230.
[11]	邹杨, 洪大情, 夏菊花, 何强, 李贵森,. 血清白蛋白与维持性血液透析患者心血管钙化的关系[J]. 内科理论与实践, 2018, 13(04): 218-222.
[12]	晏焕青, 王鹤定, 朱彤莹,. 腹膜透析相关性腹膜炎预后的危险因素研究[J]. 内科理论与实践, 2018, 13(03): 165-169.
[13]	鲁嘉越, 占雅萍, 张伟明, 李萍, 刘上, 朱旻霞, 蔡宏, 倪兆慧. 维持性血液透析患者抑郁发生情况及相关因素分析[J]. 诊断学理论与实践, 2017, 16(04): 390-393.
[14]	李艳秀, 王勇, 左祥荣, 曹权,. 早期短时静脉-静脉血液透析滤过对重症急性胰腺炎病人合并急性肾损伤的治疗[J]. 外科理论与实践, 2012, 17(06): 673-677.
[15]	宦红娣, 张景红, 张军力, 陆春来, 陆蓓莉, 李萍, 杨峻, 吴晓梅, 杨黄,. 血液灌流对维持性血液透析患者高磷血症的影响[J]. 诊断学理论与实践, 2011, 10(03): 221-225.